论文部分内容阅读
目的探讨埃索美拉唑联合莫沙比利治疗反流性食管炎的临床疗效。方法将120例反流性食管炎患者随机治疗组和对照组,治疗组给予埃索美拉唑40mg,1次/d,莫沙比利5mg,3次/d联合治疗;对照组给予奥美拉唑40mg,1次/d,莫沙比利5mg,3次/d联合治疗。治疗8周后,评价其症状缓解和内镜下改变的情况。结果治疗组和对照组在临床症状缓解和内镜下改变方面比较均差异有统计学意义(P<0.05)。结论埃索美拉唑治疗反流性食管炎的疗效明显优于奥美拉唑。
Objective To investigate the clinical efficacy of esomeprazole combined with mosapride in the treatment of reflux esophagitis. Methods 120 patients with reflux esophagitis randomized treatment group and control group, the treatment group were given esomeprazole 40mg, 1 / d, mosapride 5mg, 3 times / d combination treatment; the control group was given Ogilvy & Mather Lazole 40mg, 1 time / d, mosapride 5mg, 3 times / d combination therapy. After 8 weeks of treatment, their symptom relief and endoscopic changes were evaluated. Results There were significant differences between the treatment group and the control group in clinical symptoms and endoscopic changes (P <0.05). Conclusion Esomeprazole is superior to omeprazole in the treatment of reflux esophagitis.